Cellerant Therapeutics' Debt Round

Cellerant Therapeutics raised a round of funding on August 31, 2011.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies…

Articles about Cellerant Therapeutics' Debt Round: